Other

Motion capture examines dance techniques

WAAPA dance students are set to take part in a world-first biomechanical study that tracks their training, technique and injuries as they develop as professional performers.

Sep 29, 2014
popularity not rated yet | comments 0

Organ donation – do we opt-in or opt-out?

Researchers say there should be an international data base containing the very latest information about organ donations and transplants so policy makers can make informed decisions on whether to adopt an ...

Sep 24, 2014
popularity not rated yet | comments 0

US cancer doctor convicted of poisoning lover

(AP)—A cancer researcher in Texas was convicted Friday of aggravated assault for poisoning her colleague, who was also her lover, by lacing his coffee with a sweet-tasting chemical found in antifreeze.

Sep 26, 2014
popularity not rated yet | comments 0

3 from FDNY who worked at ground zero die in 1 day

(AP)—Three retired firefighters who worked at ground zero have died on the same day from cancer, an illness that many fear might be connected to toxic World Trade Center dust released on Sept. 11, fire officials said Thursday.

Sep 26, 2014
popularity 5 / 5 (1) | comments 0

Testes size correlates with men's involvement in toddler care

Men with smaller testes than others are more likely to be involved in hands-on care of their toddlers, a new study conducted by anthropologists at Emory University finds. The Proceedings of the National Academy of Sciences (PNAS) ...

Sep 09, 2013
popularity 3.6 / 5 (21) | comments 11 | with audio podcast

20 years of leptin – the obesity related hormone

2014 marks the 20th anniversary of the discovery of leptin – the hormone that tells our brains when we've eaten enough and the first reported genetic basis for obesity. The discovery will be celebrated ...

Sep 25, 2014
popularity not rated yet | comments 0

Valeant pitches potential eye drug, research focus

Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.

Sep 25, 2014
popularity not rated yet | comments 0